A Study of TQB2450 Injection in Subjects With PD-L1 Positive Recurrent or Metastatic Cervical Cancer

A Clinical Study of PD-L1 Antibody ZKAB001（Drug Code） in Recurrent or Metastatic Cervical Cancer

NCT03676959 ·Status: UNKNOWN ·Phase: PHASE1

A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer

NCT05998941 ·Status: WITHDRAWN ·Phase: PHASE2

SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer

NCT07256236 ·Status: RECRUITING ·Phase: PHASE2

HPV-E6-Specific Anti-PD1 TCR-T Cells in the Treatment of HPV-Positive NHSCC or Cervical Cancer

NCT03578406 ·Status: COMPLETED ·Phase: PHASE1

A Study in Recurrent or Metastatic Cervical Cancer Patients With PD-L1 Positive

NCT03808857 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy and Safety of LB1410 Plus Lenvatinib With or Without LB4330 in Advanced Recurrent/Metastatic Cervical Cancer

NCT07177716 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3

Efficacy and Safety Study of First-line Treatment With SG001 Plus Chemotherapy ± Bevacizumab Versus Placebo Plus Chemotherapy ±Bevacizumab for Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1)

NCT05715840 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Study of Tiragolumab Plus Atezolizumab and Atezolizumab Monotherapy in Participants With Metastatic and/or Recurrent PD-L1-Positive Cervical Cancer

NCT04300647 ·Status: COMPLETED ·Phase: PHASE2

To Evaluate the Efficacy and Safety of SCB01A in Subjects With r/m Squamous Cell Head and Neck Cancer

NCT03020823 ·Status: TERMINATED ·Phase: PHASE2

A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

NCT01602315 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Phase II Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Cervical Cancer

NCT05557565 ·Status: UNKNOWN ·Phase: PHASE2

A Study of MEHD7945A Versus Cetuximab in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of The Head And Neck

NCT01577173 ·Status: COMPLETED ·Phase: PHASE2

QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

NCT05446883 ·Status: UNKNOWN ·Phase: PHASE3

A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Recurrent/Metastatic Head and Neck Cancers

NCT04902027 ·Status: COMPLETED ·Phase: PHASE1

Study of SCB01A in Patient With Head and Neck Cancer

NCT02488629 ·Status: TERMINATED ·Phase: PHASE2

QL1706 Plus Chemotherapy as Neoadjuvant Therapy for Locally Advanced Cervical Cancer: A Phase II Trial

NCT07286253 ·Status: RECRUITING ·Phase: PHASE2

A Study of Chemoradiotherapy With SHR-1316 For Treatment of Locally Advanced Cervical Cancer

NCT06237257 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Belotecan (CKD-602) in Recurrent or Progressive Carcinoma of Uterine Cervix

NCT00430144 ·Status: COMPLETED ·Phase: PHASE2

Decitabine and Nivolumab in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

NCT07216833 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Cabozantinib Plus Pembrolizumab for Recurrent, Persistent and/or Metastatic Cervical Cancer

NCT04230954 ·Status: TERMINATED ·Phase: PHASE2

DX-8951f in Treating Women Who Have Advanced or Recurrent Cancer of the Cervix

NCT00004866 ·Status: COMPLETED ·Phase: PHASE2

Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer

NCT01254734 ·Status: TERMINATED ·Phase: NA

Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer

NCT00039442 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01

NCT05570422 ·Status: RECRUITING ·Phase: PHASE1

Study of Monalizumab and Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

NCT02643550 ·Status: COMPLETED ·Phase: PHASE1/PHASE2